Statistical challenges in the evaluation of surrogate endpoints in randomized trials
- 1 December 2002
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 23 (6) , 607-625
- https://doi.org/10.1016/s0197-2456(02)00236-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- On meta-analytic assessment of surrogate outcomesBiostatistics, 2000
- The validation of surrogate endpoints in meta-analyses of randomized experimentsBiostatistics, 2000
- Statistical issues for HIV surrogate endpoints: point/counterpointStatistics in Medicine, 1998
- Criteria for the Validation of Surrogate Endpoints in Randomized ExperimentsPublished by JSTOR ,1998
- Meta-analysis for the evaluation of potential surrogate markersStatistics in Medicine, 1997
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids researchStatistics in Medicine, 1994
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- Surrogate endpoints in clinical trials: CancerStatistics in Medicine, 1989